REGISTER RECORD · ctis

2024-514702-31-00

Daratumumab in combination with Carfilzomib, Pomalidomide and Dexamethasone (DCPD) in patients with multiple myeloma induced acute renal failure - "Time is Kidney in the Treatment of myeloma Cast nephropathy" The TIKTAC phase II trial (Pilot-study)

AS THE REGISTER RECORDS IT

Status and dates

Status as listedThe register records no status for this entry.
Register last updated2024-10-29
Retrieved by this site2026-10-03
Sourcehttps://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514702-31-00

What this record shows

This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.

All records · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.